컨텐츠 내용을 수정할 수 있습니다
Emergency drugs act within minutes on a problem that is killing the client now. Know the target of each one:
| Drug | Dose and route | Key point |
|---|---|---|
| Epinephrine (adrenaline) 1 mg/mL — prototype | 0.01 mg/kg IM, maximum 0.5 mg in adults and 0.3 mg in children, mid-outer thigh; repeat every 5–15 minutes if needed | First, immediately, no absolute contraindication. Auto-injectors 0.1 / 0.15 / 0.3 mg; nasal spray 1 mg (15 to under 30 kg) or 2 mg (30 kg or more) |
| Epinephrine IV infusion | Refractory anaphylaxis, by experienced staff with monitoring | Never give 1 mg/mL undiluted IV push in anaphylaxis |
| IV crystalloid | Large volumes for hypotension | Position supine with legs raised |
| Glucagon | Anaphylaxis not responding to epinephrine in clients on beta blockers: 1–5 mg IV over 5 minutes, then infusion 5–15 mcg/min | Vomiting — protect airway |
| Albuterol (salbutamol) inhaled | Persistent wheeze after epinephrine | Adjunct |
| H₁ antihistamine (cetirizine, diphenhydramine) | Itching, hives | Adjunct only |
| Corticosteroid | Not first-line; not proven to prevent biphasic reactions | Adjunct only |
| Emergency | Drug and usual adult dose | Key point |
|---|---|---|
| Suspected ACS | Aspirin 162–325 mg chewed (non-enteric-coated) | Not if allergic or actively bleeding |
| Ischemic chest pain | Nitroglycerin 0.4 mg SL every 5 minutes, up to 3 doses | Hold if SBP < 90 mmHg, HR < 50 or > 100/min, suspected RV infarction, or PDE-5 inhibitor within 24 h (sildenafil, vardenafil) / 48 h (tadalafil) |
| Hypoxemia in ACS | Oxygen if SpO₂ < 90% | Routine oxygen is not given to normoxic clients |
| Acute pulmonary edema | IV furosemide; nitroglycerin if BP allows; noninvasive ventilation | Morphine is no longer routine |
| Status epilepticus (≥ 5 minutes) | IV lorazepam 0.1 mg/kg (max 4 mg per dose, may repeat once) or IM midazolam 10 mg (> 40 kg) | Then fosphenytoin, valproate, or levetiracetam at 20–40 minutes |
| Hypoglycemia, unable to swallow | IV dextrose (e.g., 25 g as 50 mL of 50% or 250 mL of 10%), or glucagon 1 mg IM/SC (0.5 mg for children under 25 kg) or 3 mg intranasal | Recheck glucose in 15 minutes; give food when awake |
| VF / pulseless VT; asystole / PEA | Epinephrine 1 mg IV/IO every 3–5 minutes; amiodarone 300 mg then 150 mg or lidocaine for refractory VF/pVT | Epinephrine as soon as possible in nonshockable rhythms |
| Symptomatic bradycardia | Atropine 1 mg IV every 3–5 minutes, max 3 mg | Then pacing or epinephrine/dopamine infusion |
| Stable SVT | Adenosine 6 mg rapid IV push + flush, then 12 mg | Brief asystole is expected |
| Hyperkalemia with ECG changes | IV calcium gluconate; regular insulin IV with dextrose; inhaled albuterol | Calcium protects the heart but does not lower K⁺ |
| Torsades de pointes | Magnesium sulfate 1–2 g IV | Stop QT-prolonging drugs |
| Severe preeclampsia / eclampsia | Magnesium sulfate IV per obstetric protocol | Antidote: calcium gluconate |
| Drug | Key adverse effects |
|---|---|
| Epinephrine | Expected: pallor, tremor, anxiety, palpitations. Serious: tachydysrhythmias, hypertension, myocardial ischemia, pulmonary edema — mostly with IV overdose |
| Antihistamines (first generation) | Sedation, anticholinergic effects, paradoxical agitation in children; can mask progression of anaphylaxis |
| Aspirin | Bleeding, GI irritation, bronchospasm in aspirin-exacerbated respiratory disease |
| Nitroglycerin | Hypotension, headache, reflex tachycardia, dizziness |
| Furosemide | Hypotension, hypokalemia, hypomagnesemia, ototoxicity with rapid high IV doses |
| Benzodiazepines | Respiratory depression, hypotension, sedation |
| Dextrose 50% | Vesicant — tissue necrosis if extravasated; hyperglycemia |
| Glucagon | Nausea and vomiting, hyperglycemia |
| Atropine | Tachycardia, dry mouth, urinary retention, confusion |
| Adenosine | Flushing, chest pressure, dyspnea, brief asystole; bronchospasm |
| Amiodarone | Hypotension, bradycardia; long-term lung, thyroid, liver toxicity |
| Calcium | Bradycardia with rapid push; calcium chloride is a vesicant (central line preferred) |
| Insulin + dextrose | Hypoglycemia (for several hours) |
| Magnesium sulfate | Flushing, hypotension; toxicity → loss of reflexes, respiratory depression |
Listed in priority order.
| Situation | Findings | Action / antidote |
|---|---|---|
| Epinephrine route or dose error (IV push of 1 mg/mL, or 1 mg given instead of 0.3–0.5 mg) | Severe hypertension, VT, chest pain, pulmonary edema, stroke | Stop, notify, monitor; short-acting — supportive care |
| Accidental auto-injector into finger or hand | Pale, cold, painful digit | Report; warm soaks; phentolamine in some cases |
| Benzodiazepine oversedation | Respiratory depression | Ventilation first; flumazenil only in selected clients (seizure risk in dependence) |
| Opioid given in ACS or pulmonary edema | Respiratory depression | Naloxone titrated |
| Magnesium toxicity | Loss of patellar reflexes, RR < 12/min, oliguria | Stop infusion; calcium gluconate 10%, 10 mL (1 g) IV over about 3 minutes |
| Insulin–dextrose hypoglycemia | Sweating, confusion | Dextrose; frequent glucose checks |
| Dextrose extravasation | Swelling, pain, necrosis | Stop, notify, follow extravasation protocol |
다음 이론을 계속 학습하려면 로그인하세요.
로그인하고 계속 학습필기노트, 하이라이터, 메모는 잘 쓰고 있어?
내보내줘운영진이 검토할게요!
마이페이지에서 차단한 회원을 관리할 수 있어요.